{"ok":true,"entry":{"slug":"shatavari","kind":"supplement","name":"shatavari","aliases":["Asparagus racemosus"],"brands_sg":["Organic India","Himalaya","Swanson Vitamins","Paradise Herbs","Nutricost"],"class":"botanical","tags":["womens-health"],"use_for":"studied in pcos and as a milk-supply herb; evidence thin","use_after":null,"use_duration":"the pcos trial ran 12 weeks, checked at weeks 4, 8 and 12","take_with":"the trial capsule was swallowed after a meal, with water","pros":["one 12-week double-blind rct in 70 women with pcos","no serious adverse events in that trial"],"cons":["ovarian volume, bmi and hormone levels did not shift","cochrane rates milk-supply evidence low to very low","sg bars menstrual and hormonal claims (table 6)"],"dose_note":"the 2026 randomised, double-blind, placebo-controlled trial gave one capsule containing 300 mg of a standardised shatavari root extract once daily after a meal with water for 12 weeks, in 70 women aged 20 to 40 with pcos, of whom 66 completed; at 12 weeks ovarian volume did not differ from placebo and bmi, hormone levels and laboratory parameters were unchanged, while perceived stress score fell, follicular count decreased and endometrial thickness increased; cochrane's 2020 review of oral galactagogues includes shatavari among 27 natural-galactagogue studies but rates the overall certainty of evidence low to very low; no rda, ul, fda daily value or hsa singapore daily limit exists for shatavari","dosage":{"ul":null,"unit":"mg","fda_dv":null,"rda_ai":null,"ul_status":"none_established","population":"general adult","hsa_max_daily":null},"ul_status":"none_established","sg_class":null,"cautions":["mild to moderate adverse events were reported by 11.4% on shatavari and 8.5% on placebo in the 12-week trial","cochrane found reporting of adverse effects across galactagogue trials too limited to pool","not listed in hsa's prohibited or restricted annexes — that is absence of a listing, not a safety finding"],"clashes":[],"sources":[{"id":"shatavari_pcos2026_design","url":"https://europepmc.org/article/PMC/PMC12971452","label":"Efficacy and safety of Shatavari root extract in women with Polycystic Ovarian Syndrome: a randomized, double-blind, placebo-controlled trial (Frontiers in Endocrinology 2026) — methods","quote":"This prospective, randomized, double-blind, placebo-controlled trial was conducted on women aged 20-40 years for 12 weeks. Seventy participants were randomized into Shatavari root extract (SHT, n=35) and placebo (PL, n=35) groups.","accessed":"2026-08-27"},{"id":"shatavari_pcos2026_dose","url":"https://europepmc.org/article/PMC/PMC12971452","label":"Frontiers in Endocrinology 2026 shatavari PCOS trial — study interventions (product and daily amount)","quote":"a Shatavari capsule (a light brown capsule containing 300 mg Shatavari root extract) … Participants were instructed to take one capsule after a meal, once daily with water, for 12 weeks.","accessed":"2026-08-27"},{"id":"shatavari_pcos2026_results","url":"https://europepmc.org/article/PMC/PMC12971452","label":"Frontiers in Endocrinology 2026 shatavari PCOS trial — results","quote":"At 12 weeks, Ovarian volume did not differ significantly between groups (p= 0.254) … No significant differences were observed in BMI, hormonal levels, or laboratory parameters.","accessed":"2026-08-27"},{"id":"shatavari_pcos2026_safety","url":"https://europepmc.org/article/PMC/PMC12971452","label":"Frontiers in Endocrinology 2026 shatavari PCOS trial — safety","quote":"No serious adverse events occurred; mild to moderate events were reported in 11.4% (SHT) and 8.5% (PL) of participants, all manageable with standard therapy and not related to the intervention.","accessed":"2026-08-27"},{"id":"cochrane2020_shatavari","url":"https://europepmc.org/abstract/MED/32421208","label":"Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants (Foong et al., Cochrane Database of Systematic Reviews 2020) — natural galactagogues studied","quote":"Twenty-seven studies compared natural oral galactagogues (banana flower, fennel, fenugreek, ginger, ixbut, levant cotton, moringa, palm dates, pork knuckle, shatavari, silymarin, torbangun leaves or other natural mixtures) with placebo or no treatment.","accessed":"2026-08-27"},{"id":"cochrane2020_certainty","url":"https://europepmc.org/abstract/MED/32421208","label":"Foong et al., Cochrane Database of Systematic Reviews 2020 — certainty of evidence and adverse-effect reporting","quote":"The overall certainty of evidence was low to very low because of high risk of biases … There was limited reporting of adverse effects, none of which could be meta-analysed.","accessed":"2026-08-27"},{"id":"hsa_prohibited","url":"https://file.go.gov.sg/hsa-chp-prohibited-restricted-ing-guidelines.pdf","label":"HSA Singapore — Guidelines on Prohibited and Restricted Ingredients in Health Supplements and Traditional Medicines, GL-CHPB-1-012 Rev. No. 001 (October 2025), Annex A (118 rows) and Annex B (4 rows) — shatavari / Asparagus racemosus is NOT LISTED in either annex; Annex A runs 9. Asarum heterotropoides then 10. Aspidosperma quebracho-blanco, and 95. Senna alexandria then 96. Silver and its salts, where 'Asparagus' and 'Shatavari' rows would fall","quote":"The objective of this guideline is to highlight the substances of concern when used in HS and TM and is not meant to be an exhaustive list.","accessed":"2026-08-27"},{"id":"hsa_hs_guidelines","url":"https://file.go.gov.sg/hsa-hs-guidelines.pdf","label":"HSA Singapore — Health Supplements Guidelines GL-CHPB-3-001 Rev. No. 020 (January 2026), clause 4.8 with Tables 4–5 (vitamins and minerals only — no botanical rows)","quote":"4.8 HS for use by the general adult population should not contain vitamins and minerals exceeding the stipulated limits stated in Tables 4 and 5.","accessed":"2026-08-27"},{"id":"hsa_claims_table6","url":"https://file.go.gov.sg/hsa-hs-guidelines.pdf","label":"HSA Singapore — Health Supplements Guidelines GL-CHPB-3-001 Rev. No. 020 (January 2026), clause 6.6 and Table 6 (diseases/conditions not allowed for health supplements), reproductive-system row","quote":"HS must not be labelled, advertised or promoted for any specific medicinal purpose … Reproductive system: Menstrual disorders, sexual dysfunction, infertility, frigidity, impotency, conception, pregnancy","accessed":"2026-08-27"},{"id":"iherb_sg","url":"https://sg.iherb.com/c/shatavari","label":"iHerb Singapore — Shatavari category page, default listing order","quote":"1 - 9 of 9 results: Organic India, Shatavari; Himalaya, Organic Shatavari; Swanson Vitamins, Shatavari Root Extract Standardized 500 mg; Organic India, Shatavari 180 caps; Paradise Herbs, Shatavari Extract; Nutricost, Shatavari 600 mg","accessed":"2026-08-27"}],"brand_certs":null,"updated_at":"2026-08-29T16:16:31.341231+08:00"},"disclaimer":"kozen-x is not a medical device and does not give medical advice. it lists what published sources have written down. absence of a record is not the same as safe."}